[1] Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020[J]. Cancer Commun (Lond), 2021,41(11):1183-1194. DOI: 10.1002/cac2.12207.
[2] Khan NAJ, Tirona M. An updated review of epidemiology, risk factors, and management of male breast cancer[J]. Med Oncol, 2021,38(4):39. DOI: 10.1007/s12032-021-01486-x.
[3] 杨韵贤,李世梅,姚继祎,等. 乳腺癌肿物的超声特点与术后复发的logistic回归分析[J]. 中国超声医学杂志,2021,37(5):509-512. DOI:10.3969/j.issn.1002-0101. 2021.05.011.
[4] Fujihara M, Yamasaki R, Ito M, et al. Risk factors of local recurrence following implant-based breast reconstruction in breast cancer patients[J]. BMC Womens Health, 2021,21(1):147. DOI: 10.1186/s12905-021-01287-4.
[5] Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer[J]. Br J Cancer, 2021,124(1):13-26. DOI: 10.1038/s41416-020-01161-4.
[6] 刘瑛. 超声检查在乳腺癌术后局部区域复发监测中的应用价值[D]. 衡阳:南华大学,2015.
[7] 郝如意,陈武,刘晓芳,等. 乳腺癌多模态超声边缘带征象与预后因素关系的研究[J]. 医学研究杂志,2022,51(12):84-88,136. DOI:10.11969/j.issn.1673-548X.2022.12.017.
[8] 黑欢欢,冯忠波,王梦祥.基于多模态MRI列线图治疗前评估对乳腺癌术后复发的预测价值[J].临床放射学杂志,2022,41(7):1276-1281.DOI:10.13437/j.cnki.jcr.2022.07.009.
[9] 中华人民共和国国家卫生和计划生育委员会. 原发性乳腺癌规范化诊疗指南(试行)[J/CD]. 中国医学前沿杂志(电子版),2013,5(5):30-37. DOI:10.3969/j.issn.1674-7372. 2013.05.013.
[10] 罗洁,刘世伟,张蒲蓉,等. 血清HE4、VEGF、MCP-1及CCL20与乳腺癌患者保乳术后局部复发的关系研究[J]. 现代生物医学进展,2022,22(14):2778-2783. DOI:10.13241/j.cnki.pmb.2022.14.036.
[11] Bluming AZ. Hormone replacement therapy after breast cancer: it is time[J]. Cancer J, 2022,28(3):183-190. DOI: 10.1097/PPO.0000000000000595.
[12] Duan Y, Song X, Guan L, et al. Comparative study of pathological response evaluation systems after neoadjuvant chemotherapy for breast cancer: developing predictive models of multimodal ultrasound features including shear wave elastography combined with puncture pathology[J]. Quant Imaging Med Surg, 2023,13(5):3013-3028. DOI: 10.21037/qims-22-910.
[13] Zhu JY, He HL, Jiang XC, et al. Multimodal ultrasound features of breast cancers: correlation with molecular subtypes[J]. BMC Med Imaging, 2023,23(1):57. DOI: 10.1186/s12880-023-00999-3.
[14] 刘芙芸,赵丽丽,刘富霞,等. 多模态超声特征与乳腺癌新辅助化疗患者术后病理缓解程度及BCL-2表达的相关性[J]. 中华内分泌外科杂志,2021,15(5):483-487. DOI:10.3760/cma.j.cn.115807-20210709-00213.
[15] 何小芳,周敏,熊朝月,等. 乳腺癌超声征象及其术后复发的危险因素分析[J]. 东南国防医药,2022,24(3):274-277. DOI:10.3969/j.issn.1672-271X.2022.03.011.
[16] 胡卫,刘良进. DCE-MRI结合DWI评估肝癌介入治疗疗效的应用价值[J]. 国际医药卫生导报,2022,28(5):719-724. DOI:10.3760/cma.j.issn.1007-1245.2022.05.029.
[17] Fowler AM, Strigel RM. Clinical advances in PET-MRI for breast cancer[J]. Lancet Oncol, 2022,23(1):e32-e43. DOI: 10.1016/S1470-2045(21)00577-5.
[18] Pötsch N, Vatteroni G, Clauser P, et al. Contrast-enhanced mammography versus contrast-enhanced breast MRI: a systematic review and meta-analysis[J]. Radiology, 2022,305(1):94-103. DOI: 10.1148/radiol.212530.
[19] 孙祥寅,董银英,陆海军,等. 3.0T动态增强MRI的背景实质增强和乳腺癌临床分期、分子病理类型及术后胸壁复发的相关性研究[J]. 临床医学进展,2022,12(7):6335-6344. DOI:10.12677/ACM.2022.127915.
[20] 海江,张海莲,杨慧,等. 乳腺癌MRI IVIM-DWI参数与MIP-1α、PDGF表达相关性及其临床诊断价值研究[J]. 医疗卫生装备,2022,43(1):67-71. DOI:10.19745/j.1003-8868.2022015.
[21] 牛微,罗娅红,于韬,等. 基于动态对比增强MRI的肿瘤血流动力学及形态学特征预测乳腺癌术后复发时间的价值[J]. 中华放射学杂志,2020,54(3):209-214. DOI:10.3760/cma.j.issn.1005-1201.2020.03.007.
[22] Guillaumin JB, Djerroudi L, Aubry JF, et al. Proof of concept of 3-D backscatter tensor imaging tomography for non-invasive assessment of human breast cancer collagen organization[J]. Ultrasound Med Biol, 2022,48(9):1867-1878. DOI: 10.1016/j.ultrasmedbio. 2022.05.017.
[23] Fincke J, Zhang X, Shin B, et al. Quantitative sound speed imaging of cortical bone and soft tissue: results from observational data sets[J]. IEEE Trans Med Imaging, 2022,41(3):502-514. DOI: 10.1109/TMI.2021.3115790.
[24] Badal K, Ali R, Warner WA, et al. Factors associated with breast cancer recurrence and survival at Sangre Grande Hospital, Trinidad[J]. Cancer Causes Control, 2021,32(7):763-772. DOI: 10.1007/s10552-021-01427-z.
[25] Chou HH, Chung WS, Ding RY, et al. Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment[J]. BMC Surg, 2021,21(1):160. DOI: 10.1186/s12893-021-01158-7.
[26] 何梅,赵振慧,李迅. 乳腺癌规范化根治术后复发转移的多因素调查[J]. 河北医药,2021,43(11):1735-1738,1742. DOI:10.3969/j.issn.1002-7386.2021.11.033.
|